Articles with "etdrs letters" as a keyword



Photo from wikipedia

Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data

Sign Up to like & get
recommendations!
Published in 2017 at "Graefe's Archive for Clinical and Experimental Ophthalmology"

DOI: 10.1007/s00417-017-3681-2

Abstract: Dear Editor: We would to address several challenges that have arisen from the study by Chatziralli et al. [1], which can be specifically summarized below. Several relevant data are missing from the study (Table 1).… read more here.

Keywords: study; final results; etdrs letters; aflibercept ... See more keywords
Photo by aaronburden from unsplash

Prognostic Factors for Visual Outcomes in Closed Idiopathic Macular Holes after Vitrectomy: Outcomes at 4 Years in a Monocentric Study

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Ophthalmology"

DOI: 10.1155/2022/1553719

Abstract: Purpose To identify predictive factors of visual outcomes in the eyes after successful macular hole (MH) surgery. Methods It is a retrospective monocentric study of the eyes that underwent successful vitrectomy for full-thickness MH in… read more here.

Keywords: gain etdrs; factors visual; monocentric study; visual outcomes ... See more keywords
Photo by averey from unsplash

Short-term effectiveness prognostic factors after dexamethasone intravitreal implant in macular edema due to retinal vein occlusion.

Sign Up to like & get
recommendations!
Published in 2021 at "European journal of ophthalmology"

DOI: 10.1177/11206721211032520

Abstract: INTRODUCTION The aim of this study was to describe functional and anatomical changes (best-corrected visual acuity [BCVA], central macular thickness [CMT], and central macular volume [CMV]) in patients with macular edema (ME) secondary to retinal… read more here.

Keywords: cmv; vein occlusion; bcva etdrs; etdrs letters ... See more keywords
Photo by finnnyc from unsplash

Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies

Sign Up to like & get
recommendations!
Published in 2021 at "Medicina"

DOI: 10.3390/medicina57010064

Abstract: Background and objectives: Choroideremia (CHM) is an X-linked recessive chorioretinal dystrophy caused by mutations involving the CHM gene. Gene therapy has entered late-phase clinical trials, although there have been variable results. This review gives a… read more here.

Keywords: gene therapy; study; etdrs letters; clinical trials ... See more keywords